Literature DB >> 10736707

Assays for activation of recombinant expressed opsins by all-trans-retinals.

M Han1, T P Sakmar.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10736707     DOI: 10.1016/s0076-6879(00)15848-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.

Authors:  Olaf Fritze; Sławomir Filipek; Vladimir Kuksa; Krzysztof Palczewski; Klaus Peter Hofmann; Oliver P Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  A rhodopsin exhibiting binding ability to agonist all-trans-retinal.

Authors:  Hisao Tsukamoto; Akihisa Terakita; Yoshinori Shichida
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

3.  Measurement of Slow Spontaneous Release of 11-cis-Retinal from Rhodopsin.

Authors:  He Tian; Thomas P Sakmar; Thomas Huber
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

4.  11-cis- and all-trans-retinols can activate rod opsin: rational design of the visual cycle.

Authors:  Masahiro Kono; Patrice W Goletz; Rosalie K Crouch
Journal:  Biochemistry       Date:  2008-06-19       Impact factor: 3.162

5.  Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II.

Authors:  Xavier Deupi; Patricia Edwards; Ankita Singhal; Benjamin Nickle; Daniel Oprian; Gebhard Schertler; Jörg Standfuss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-23       Impact factor: 11.205

6.  Crystallization scale preparation of a stable GPCR signaling complex between constitutively active rhodopsin and G-protein.

Authors:  Shoji Maeda; Dawei Sun; Ankita Singhal; Marcello Foggetta; Georg Schmid; Joerg Standfuss; Michael Hennig; Roger J P Dawson; Dmitry B Veprintsev; Gebhard F X Schertler
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.